Article

New system classifies vitreomacular disease, provides common language

An international panel of ophthalmologists have developed a classification system of vitreomacular diseases, with the goals of objectivity based on optical coherence tomography (OCT) findings and ease of use.

 

Boston-An international panel of ophthalmologists have developed a classification system of vitreomacular diseases, with the goals of objectivity based on optical coherence tomography (OCT) findings and ease of use.

The new imaging-based classification system was needed because the Gass classification for macular holes was outdated. The Gass system was devised decades before the introduction of spectral-domain OCT, which has provided a better understanding of the pathogenesis of diseases of the vitreomacular interface diseases and is predictive of surgical outcomes.

The classification system was also needed because of the recently FDA-approved ocriplasmin (Jetra, ThromboGenics), a new therapy for some diseases, said Jay Duker, MD, professor and chairman of ophthalmology, Tufts University School of Medicine, Boston.

“We wanted the system to be applicable to clinical practice, useful for clinical trials, and predictive of surgical outcomes,” Dr. Duker said. “The overall goal was for ophthalmologists to speak a common language about these diseases.”

One finding (vitreomacular adhesion) and four diseases (vitreomacular traction, full-thickness macular hole, lamellar macular hole, and epiretinal membrane) are included in the classification, which the panel published in Ophthalmology (2013;120:261119).

When converting from the old Gass classification system to the new international classification system:

·      Stage 0 macular hole is equivalent to vitreomacular adhesion in the contralateral eye

·      Stage 1 macular hole is equivalent to vitreomacular traction

·      Stage 2 macular hole is equivalent to full-thickness macular hole (small/medium hole with/without vitreomacular traction)

·      Stage 3 macular hole is equivalent to full-thickness macular hole (medium/large hole with/without vitreomacular traction)

·      Stage 4 macular hole is equivalent to full-thickness macular hole (vitreomacular traction released with any size macular hole)

“Vitreomacular adhesion is a normal stage of progression of posterior vitreous detachment,” Dr. Duker noted. “Abnormalities result from persistence of adhesion with traction (vitreomacular traction), which can lead to severe retinal anatomic abnormalities, full-thickness macular holes, epiretinal membranes, lamellar macular holes, and macular schisis.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.